1.. Introduction {#s1}
================

The neuropathological hallmark of Parkinson\'s disease (PD) is the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc), affecting about 1--2% of the human population older than 65 years.^[@DSM007C1]^ It is characterized by the clinical symptoms of resting tremor, muscular rigidity, postural instability, a positive response to the administration of [l]{.smallcaps}-DOPA, and the presence of cytoplasmic inclusions in postmortem brains, Lewy Bodies.^[@DSM007C2]^ Despite its mostly sporadic onset and a high discordance rate in monozygotic twins,^[@DSM007C3]^ several human linkage studies had been initiated to determine susceptibility genes for this disease.^[@DSM007C4]^ In the Online Mendelian Inheritance in Man (OMIM) database, 13 PD loci have been recorded: PARK1,^[@DSM007C5]^ PARK2,^[@DSM007C6]--[@DSM007C9]^ PARK3,^[@DSM007C10]^ PARK4,^[@DSM007C11],[@DSM007C12]^ PARK5,^[@DSM007C13]^ PARK6,^[@DSM007C14],[@DSM007C15]^ PARK7,^[@DSM007C16],[@DSM007C17]^ PARK8,^[@DSM007C18]^ PARK9,^[@DSM007C19],[@DSM007C20]^ PARK10,^[@DSM007C21]^ PARK11,^[@DSM007C22],[@DSM007C23]^ PaRK12,^[@DSM007C23],[@DSM007C24]^ and PARK13.^[@DSM007C25]^ Furthermore, genome-wide analyses of multiplex PD families provided evidence for linkage to regions on different chromosomes.^[@DSM007C21],[@DSM007C22],[@DSM007C24],[@DSM007C26]--[@DSM007C29]^ The PARK loci are sometimes larger than 10 Mb and can contain hundreds of genes. In case of the genome-wide linkage studies for a complex, multifactorial disease such as PD, the regions with high LOD scores are rarely smaller than 20 cM.^[@DSM007C29]^ The differences among independent studies and the size of the suggested susceptibility regions make the searches for the underlying mutations irremediably a time-consuming process.

For several PARK loci, the searches have been successful. Mutations in α-*synuclein* (PARK1 and PARK4), *DJ-1* (PARK7), *parkin* (PARK2), *PINK1* (*PTEN-induced putative kinase*) (PARK6), *LRRK2 (leucine-rich repeat kinase 2*) (PARK8), *UCHL1* (*ubiquitin carboxy-terminal-hydrolase-L1*) (PARK5), and *ATP13A2 (ATPase type 13A2*) (PARK9) have been identified.^[@DSM007C5],[@DSM007C30]--[@DSM007C37]^ Other studies have revealed the cytoskeletal protein *tau* (*MAPT*)^[@DSM007C36],[@DSM007C38]^ and the ligand-independent nuclear receptor *NR4A2*^[@DSM007C30],[@DSM007C39],[@DSM007C40]^ (*Nurr1*) as susceptibility genes. Although the definite role in PD of many of these genes is still discussed and controversial (especially for *NR4A2* and *UCHL1*) and the known mutations account for less than 10% of all PD cases, the investigation into the functions of the underlying genes has generated an insight into the fundamental disease pathogenesis. For example, α-*synuclein* and *parkin* turned out to be major protein components of Lewy bodies in sporadic PD.^[@DSM007C41]^ Mutations in *parkin*, *UCHL1*, and *DJ-1* suggest that abnormal protein folding and protein degradation through the ubiquitin-proteasome system is an important factor in the etiology of the disease.^[@DSM007C42],[@DSM007C43]^ *PINK1* may be involved in the phosphorylation of mitochondrial proteins in response to cellular stress, thus protecting against mitochondrial dysfunction.^[@DSM007C35]^ Interestingly, mitochondria are also the site, where the known neurotoxins for DA neurons operate, suggesting that their malfunctioning could be a major contributor to PD pathogenesis.^[@DSM007C44]^

Current or future searches for the underlying mutations in the remaining *orphan* Parkinson loci could be accelerated and widened to promoter regions and to haplotype variations, if the number of candidate genes is narrowed down by other criteria. At least seven out of the nine PD-associated genes are expressed by nigral DA neurons,^[@DSM007C45]--[@DSM007C50]^ with different expression levels and specificity. These are α-*synuclein*, *NR4A2*, *parkin*,^[@DSM007C46]^ *PINK1, tau*, *UCHL1*, and *LRRK1* (<http://www.brain-map.org>). For this reason, we propose expression (specific or non-specific) by mesDA neurons as a selection criterion to identify candidate genes in those PD loci where the underlying gene is still unknown (*orphan*). Such an approach does not make any presumption with respect to disease mechanisms. Conceptually, the same method was applied on five large PD loci using serial analysis of gene expression for a comparative expression analysis of SNpc and adjacent mesencephalon in postmortem brains.^[@DSM007C51]^ As cell-specific expression in mouse and human is very similar, we took three murine expression studies which employed fluorescent-activated cell sorting (FACS) and two unrelated subtractive methods for the identification of genes expressed by mesDA neurons.^[@DSM007C52]--[@DSM007C54]^ We collected the cDNA sequences of these expression analyses from public databases, determined the underlying genes and the corresponding gene ontology annotations \[Gene Ontology (GO)\] to obtain insight into their function. Then, we established their genetic locations and their syntenic positions on the human genome. Finally, we combined these data with existing human PD linkage studies.^[@DSM007C5]--[@DSM007C11],[@DSM007C13]--[@DSM007C24],[@DSM007C26]--[@DSM007C29],[@DSM007C55],[@DSM007C56]^

2.. Material and methods {#s2}
========================

2.1.. Transcriptome analysis {#s2a}
----------------------------

All nucleotide sequences used in this study are publicly available at <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide> and derived from three expression analyses in mouse: (i) Barrett *et al.*^[@DSM007C52]^ published 779 sequences (Accession Nos.: BE824469--BE824504, BE824506--BE824519, BE824521--BE824561, BE824563--BE824823, BE824825--BE825045, BE825047--BE825132, CK338036--CK338155). (ii) Stewart *et al.*^[@DSM007C53],[@DSM007C57],[@DSM007C58]^ published 496 cDNA sequences (Accession Nos.: AA008736, W33210--W33212, W33214--W33289, W35421--W35480, W36130--W36269, W39787--W40005, W40007--W40008, W40010--W40023, W45732). (iii) We published 160 sequences (Accession Nos.: CO436137--CO436293).^[@DSM007C54]^

Each nucleotide sequence was employed for a nucleotide-nucleotide BLAST (blastn) (basic local alignment search tool) on the nr database (non-redundant) (<http://www.ncbi.nlm.nih.gov/BLAST/>) and on the mouse genome (<http://www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html>). We then recorded those alignments with the highest scores, the lowest e-values, and highest number of hits in a single locus. BLAST results were categorized into four groups: ([@DSM007C1]) no significant alignments on mouse genome (None), ([@DSM007C2]) significant alignments with mitochondrial DNA (Mitochondrial Genes), ([@DSM007C3]) multiple high-scoring alignments on mouse genome (Multiple Hits) for ambiguous results, and ([@DSM007C4]) significant alignments on mouse genome for single hits or otherwise unambiguous results (Table [1](#DSM007TB1){ref-type="table"}). The latter group was further subdivided into: 'Genes', 'ESTs', and 'genomic Sequences'. The group 'Genes' comprises the results with high-scoring alignments in exons of single genes. In some cases, where the alignment lay in the region after the last exon or, according to the chromosome map view, in an intron of a given gene, we termed it also 'Gene', if the hit was in a UniGene cluster which was linked to the gene in the locus. With those alignments that we were unable to associate to a gene, we performed a blastn on the MmEST database. If we could associate the sequence to a previously described EST, we termed it 'EST'; otherwise, it was termed 'Genomic Sequence'.

###### 

BLAST results on mouse genome

  -------------------------------------------------- ------ --------------------------
  No significant alignments on mouse genome          262    None
  Significant alignments with mitochondrial genes    104    Mitochondrial genes
  Multiple high-scoring alignments on mouse genome   19     Multiple hits
  Significant alignments on mouse genome             1050   Genes (940)
                                                            Annotated genes (793)
                                                            Hypothetical genes (147)
                                                            ESTs (47)
                                                            Genomic sequences (63)
  -------------------------------------------------- ------ --------------------------

cDNA sequences are separated into four different categories based on the types of alignments generated. Alignments on the mouse genome were subdivided into Genes, ESTs, and genomic sequences. For the category 'Genes', we differentiated further between 'annotated' and 'hypothetical' depending on the gene RefSeq status recorded at NCBI.^72^

For all the 'Annotated Genes', 'Hypothetical Genes', and mitochondrial genes, the following data were collected from the locus link feature (<http://www.ncbi.nlm.nih.gov/LocusLink> this was replaced by <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene> during the course of this study): the gene name, gene symbol, accession number, Gene ID, and the MGI link number, if available. The latter provides a relational link to the GO library and the information related to 'biological processes', 'cellular components', and 'molecular functions'.

For all cDNA sequences categorized by 'Significant Alignments on Mouse Genome', we also registered the exact chromosomal position in kilobases (starting from the top of the short arm).

2.2.. Mapping the murine cDNA sequences to the human genome {#s2b}
-----------------------------------------------------------

For most of the murine genes, a human homolog has already been determined, normally carrying the same name and symbol. This information is registered on the Entrez Gene page together with the cytogenetic locations. When this information did not exist, we used the mouse protein sequence of the identified gene for a translated BLAST (tblastn), or the nucleotide sequence of the cDNA fragment or the GenBank accession number of the corresponding gene for a blastn on the human genome. We registered the position in kilobases on the chromosome and verified each position on the human genome by comparing the neighboring genes to those in the mouse genome and recorded the human position only if the neighboring genes also matched.

When the cytogenetic position on the human genome was determined, we compared this information with the positions of the recorded PARK loci. We aligned the human chromosome map view with the map for 'morbid/disease', described in OMIM (<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM>). When the genes, or the estimated human locations, and the cytogenetic disease locations co-localized, we called the gene a PD candidate gene. For the loci suggested by genome-wide studies, we selected those genes, which were situated ± 3 Mb from the chromosome marker (single nucleotide polymorphism (SNP)) with the highest LOD score (Table. [5](#DSM007TB5){ref-type="table"}). We are aware that this approach reduces the numbers of genes in an arbitrary manner. However, if preferred, the range can be widened with the provided data (see Supplementary Data) in order to more accurately consider asymmetry or size of each specific linkage peak.

The entire data set was collected and processed using the database program, Filemaker Pro 7.0. The latest update was in February 2007. This database is available upon request.

3.. Results {#s3}
===========

We obtained 1435 sequences from three independent studies, which had the original aim to identify genes expressed by mesDA neurons. Barrett *et al.*^[@DSM007C52]^ had isolated DA neurons from E13 ventral midbrain by FACS. This library contains genes expressed by mesDA neurons with a preference for abundant genes. The other two studies used subtractive methods to enrich for rare RNA transcripts expressed by mesDA neurons. Stewart *et al.*^[@DSM007C53],[@DSM007C57],[@DSM007C58]^ had created a single-stranded directional cDNA library from substantia nigra of 8-week-old mice subtracted with a cDNA library from cerebellum. We had used a PCR-based differential display method^[@DSM007C54]^ employing cDNA from engrailed-1/2 double-mutant and wild-type ventral midbrain during the embryonic stages when mesDA neurons disappear in the mutants.^[@DSM007C59],[@DSM007C60]^ The amplified sequences were compared to the expression profile of adult olfactory bulb, a source of DA neurons unrelated to those in the ventral midbrain. Only differentially expressed cDNA fragments were isolated and sequenced. As the original sequence analyses of the former two studies had been performed when a smaller nucleotide data set was available and in order to update our own expression analysis, we subjected the sequence data from all three screens to new BLAST searches and determined their association to genes and published ESTs, and their location on the mouse genome. The 1435 cDNA fragments generated 1050 unambiguous murine genomic hits, 19 ambiguous multiple hits, and 104 alignments with mitochondrial DNA. Two hundred and sixty-two cDNA sequences produced no significant alignments (see Table [1](#DSM007TB1){ref-type="table"} for definitions and the entire analysis, and Table [2](#DSM007TB2){ref-type="table"} for the individual libraries).

###### 

Classification of BLAST results from each library

                                                          Total analysis   Barrett^52^   Stewart^53^   Thuret^54^
  ------------------------------------------------------- ---------------- ------------- ------------- ------------
  A. Number of unique alignments per individual library                                                
  Genes^a^                                                423              150           218           77
  Hyp. genes^b^                                           80               23            39            19
  ESTs^c^                                                 32               16            12            3
  Genomic                                                 44               15            8             21
  Mitochondria                                            11               8             2             2
  Multiple hits^d^                                        14               6             4             4
  None^e^                                                 185              67            111           8
  Total^f^                                                789              285           394           134
  B. Total number of fragments^g^                                                                      
  Genes^a^                                                793              403           293           97
  Hyp. genes^b^                                           147              71            55            21
  ESTs^c^                                                 46               28            15            5
  Genomic                                                 62               30            11            21
  Mitochondria                                            104              100           2             2
  Multiple hits^d^                                        19               9             4             6
  None^e^                                                 262              138           116           8
  Total                                                   1435             779           496           160

^a^Annotated mouse genes.

^b^Hypothetical genes determined by EST clustering or predicted by automated computational genome analysis with a large open reading frame.

^c^Expressed sequencing tags.

^d^Underlying gene not identifiable, due to multiple alignments with low e-values.

^e^No hit in mouse and human genome.

^f^Number of unique alignments. Five hundred and seventy-nine unique tags were on the mouse genome (excluding mitochondria).

^g^Number of fragments that represent genes, hypothetical genes, ESTs, genomic sequences, multiple alignments, and mitochondrial genes, listed per individual library.

Out of 1050 cDNA fragments, which generated unambiguous alignments on the mouse genome, 1020 were in gene loci. Most of them aligned to exons of those genes (72.6%; 741 of 1020). Out these 1020 cDNA fragments, 181 (17.8%) lay 3′ to the last annotated exon, suggesting that substantial amounts of mRNAs isolated from brain tissue are longer at their 3′ end than mRNAs from other tissues (Table [3](#DSM007TB3){ref-type="table"}). Finally, 9.6% (98 of 1020) of the alignments lay in regions designated as introns, suggesting that they are parts of unrecorded splice variants, possibly specific for mesDA neurons.

###### 

Alignments in relation to gene loci

                                                  Total   Genomic sequences   ESTs   Genes
  ------------------- --------------------------- ------- ------------------- ------ --------
  In gene loci        Only in last exon           471                                471
                      In last and other exon(s)   132                                132^a^
                      Not in last exon            138                                138
                      After 3′ end                181     6                   16     159
                      Intron                      98      40                  10     48
                      Subtotal                    1020    46                  26     948
  Outside gene loci                               30      17                  13     
  Total                                           1050    63                  39     948

Genomic alignments were divided into three groups: 'ESTs' (3.7%), 'genomic sequences' (6.0%), and 'genes' (90.3%). Majority of the cDNA fragments that aligned with genes are aligned with the last exon. A significant number of the cDNAs aligned with the region 3′ to the last exon. See Material and Methods for details.

^a^Forty-four hits are in genes with only one exon.

The 1050 cDNA fragments represented 503 genes (423 annotated and 80 hypothetical genes), 32 ESTs, and 44 unique genomic hits with no otherwise described ESTs. Additionally, the 104 sequences that aligned to the mitochondrial DNA represented 11 mitochondrial genes (Table [2](#DSM007TB2){ref-type="table"}). To these cDNA sequences, we associated the corresponding MGI numbers, if available. This provided us with insight into their molecular function, the cellular locations of the proteins, and the associated biological process (see Supplementary Data for the entire transcriptome analysis). Several protein classes were over-represented, like, for example, those, which take part in mitochondria-related processes, in fatty acid chain metabolism, in ubiquitination, in the MAPK signaling pathways, or which are chaperones. Some of these molecular pathways were previously linked to the death of mesDA neurons, to PD, and other human neurodegenerative disorders.

The majority of the mutations, which are associated to PD, is in genes that are expressed in mesDA neurons. We, therefore, joined these expression analyses with human PD linkage and association studies,^[@DSM007C5]--[@DSM007C11],[@DSM007C13]--[@DSM007C24],[@DSM007C26]--[@DSM007C29],[@DSM007C55],[@DSM007C56]^ where no mutation has been associated thus far. For each unique mouse cDNA sequencing tag, we determined its human homolog and the corresponding cytogenetic and physical positions on the human chromosomes. We verified each locus on the human genome by identifying the neighboring genes on the mouse genome and recorded the human position only if the adjacent genes were the same. We then determined whether these positions were within OMIM (Table [4](#DSM007TB4){ref-type="table"}) and other suggestive (non-OMIM) PD loci (Table [5](#DSM007TB5){ref-type="table"}). In case of the OMIM *orphan PD* loci, we projected on the human chromosome view the map for 'morbid diseases'. In case of non-OMIM loci, we identified the genes ± 3 Mb to the SNP marker with the highest LOD score. Totally, we linked the mouse transcriptome analyses to 569 unique locations on the human genome. Nineteen of these are within *orphan* PARK loci (Table [6](#DSM007TB6){ref-type="table"}) and 51 in non-OMIM PD loci (Table [7](#DSM007TB7){ref-type="table"}).

###### 

PARK loci

  Locus     OMIM identifier  Gene      Cytogenetic location   From (kb)   To (kb)   Mb     Number of genes
  -------- ----------------- --------- ---------------------- ----------- --------- ------ -----------------
  PARK1         163890       SNCA      4q21.1-4q21.3                                       
  PARK2         602544       Parkin    6q25.3-6q26                                         
  PARK3         602404                 2p13.3-2p13.1          68.075      75.307    7.2    106
  PARK4         605543                 4p15.33-4p15.1         13.424      37.324    23.9   60
  PARK5         191342       UCHL1     4p14                                                
  PARK6         605909       PINK1     1p36.33-1p35.1                                      
  PARK7         602533       DJ1       1p36.23-1p36.22                                     
  PARK8         607060                 12q11.2-12q13.13       27.908      55.637    27.7   351
  PARK9         606693       ATP13A2   1p36.33-1p36.11                                     
  PARK10        606852                 1p33-1p32.2            47.651      55.380    7.7    76
  PARK11        607688                 2q36.1-2q37.3          219.844     243.416   23.6   216
  PARK12        300557                 Xq21-q25               75.950      129.900   40.0   356
  PARK13        610297                 2p13.1-2p11.2          75.450      84.130    8.7    39
                601828       NR4A2     2q22.1-2q23.3                                       
                603779       SNCAIP    5q23.1-q23.3                                        
                260540       MAPT      17q21.1                                             

Genomic location of PARK loci as recorded in the OMIM databank. For seven of the PARK loci, the mutated genes were identified. The number of genes is the current GenBank estimation of all annotated and predicted genes in the corresponding PARK locus. For the PARK10 locus, we used the narrow definition 1p33-1p32.2 as determined by the two genetic markers D1S2134 and D1S200, and not the entire shorter arm of chromosome 1 (1p) which contains 1232 genes.^21^

###### 

Association studies not recorded at OMIM

                                 Cytogenetic location   Genetic marker   Mb         CM Marshfield   LOD score
  ------------------------------ ---------------------- ---------------- ---------- --------------- -----------
  Bertoli-Avella (03)^27^        19p13.13               D19S221          12.6       36              2.26
                                 19p13.13               D19S840          13.7       38              
  DeStefano (01)^28^             9q34.11                D9S1825          123.3      136             1.3
                                 10q22.1                GATA121A08       70.2       88              1.07
  DeStefano (02)^56^             9q32                   D9S930           110.6      120             1.86
                                 20q11.2                D20S478          37.9       54              1.82
                                 21q21                  D21S2052         27.7       24              2.21
  Hicks (02)^55^                 5q23.3                 D5S666           120--137   135             1.6
  Li (02)^21^                    10q25.3                D10S1237         116.1      134             2.62
                                 6p21.1                 D6S1017          41.7       63              1.88
                                 5q15                   D5S1462          96.4       105             
                                 5q21.1                 Peak             100        108             1.65
                                 5q21.3                 D5S1453          105--109   115             
                                 17p13.1                D17S1303         10.8       24              1.93
  Martinez (04)^29^              2p12--q22              D2S2216          88         111             1.24
                                 2p11--q12              Peak             102        117             2.04
                                 2q12                   D2S160           107        123             1.77
                                 5q23                   D5S471           117.5      130             1.05
                                 6p12                   D6S257           56         80              1.37
                                 6q11--q13              Peak             69--73     85              1.41
                                 6q14                   D6S460           ∼82        90              1.14
                                 7p22                   D7S531           3          5               1.51
                                 11q14                  D11S4175         89.9       91              1.6
                                 19q13.3                D19S902          53.6       73              1.05
  Pankratz (03)^24^              Xq22.3                 DXS8055          113.4      71              3.1
                                 10q11.2                D10S196          51.5       70.0            2.3
  Scott (01)^26^                 5q31.1                 D5S816           135.4      139             2.39
                                 17p11.2                D17S921          14.5       36              1.92
  Two-point and multipoint LOD   17q11.2                D17S1293         32.7       56              2.28
                                 17p11.2                D17S921          14.5       36              2.02
                                 17q11.2                D17S1293         32.7       56              2.62
                                 9q33.1                 −10 cM           117.8      130             
  Multipoint LOD                 9q33.3                 D9S301 66 cM     126.3      140             2.59
                                 9q34.2                 +10 cM           132.3      150             
                                 3q13.32                D3S2460          118.7      135             1.62

For each individual study, the highest LOD scores with the associated genetic markers are listed. In these studies, the peak positions and the flanking genetic markers were given in centiMorgan on the Marshfield genetic map. We determined, when possible, the exact position in Mb on the corresponding chromosome. The average distance between the two adjacent genetic markers in each study varied between 5 and 11 cM.

###### 

Candidate genes in *Orphan* PARK loci

  No. of cDNA fragments aligning with the gene   Mouse ID    Human ID    Symbol     Human gene name                                                 Position        Locus
  ---------------------------------------------- ----------- ----------- ---------- --------------------------------------------------------------- --------------- --------
  1                                              NM_146169   XM_376062   KIAA1155   *KIAA1155 protein*                                              2p13.3          Park3
  1                                              NM_008717   NM_014497   ZFML       *Zinc finger, matrin-like*                                      2p13.2--p13.1   Park3
  1                                              NM_183138   XM_371501   MGC22014   *cDNA sequence BC037432*                                        2p13.1          Park3
  3                                              NM_080555   NM_003713   PPAP2B     *Phosphatidic acid phosphatase type 2B*                         1p32            Park10
  1                                              AA819910    Estimated   FAF1       *In locus of Fas-associated factor 1*                           1p33            Park10
  6                                              NM_009129   NM_003469   SCG2       *Secretogranin II*                                              2q35--q36       PARK11
  3                                              AK052241    NM_005544   IRS1       *Insulin receptor substrate 1*                                  2q36            PARK11
  1                                              NM_152915   NM_139072   DNER       *Delta/notch-like EGF-related receptor*                         2q37.1          PARK11
  1                                              NM_008440   NM_004321   KIF1A      *Kinesin family member 1A*                                      2q37.3          PARK11
  2                                              NM_024197   NM_004544   NDUFA10    *NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10*         2q37.3          PARK11
  1                                              NM_025437   NM_001412   EIF1AX     *Eukaryotic translation initiation factor 1A, X-linked*         Xp22.13         PARK12
  2                                              NM_019768   NM_012286   MORF4L2    *Mortality factor 4 like 2*                                     Xq22            PARK12
  3                                              NM_011123   NM_000533   PLP1       *Proteolipid protein 1*                                         Xq22            PARK12
  3                                              NM_013898   NM_004085   TIMM8A     *Translocase of inner mitochondrial membrane 8 homolog a*       Xq22.1          PARK12
  3                                              NM_016783   NM_006667   PGRMC1     *Progesterone receptor membrane component 1*                    Xq22--q24       PARK12
  7                                              NM_030688   estimated   IL1RAPL2   *After 3′ of interleukin 1 receptor accessory protein-like 2*   Xq22.2--q22.3   PARK12
  1                                              NM_133196   NM_001325   CSTF2      *Cleavage stimulation factor, 3′ pre-RNA, subunit 2*            Xq22.1          PARK12
  1                                              NM_025893   NM_173798   ZCCHC12    *Zinc finger, CCHC domain containing 12*                        Xq24            PARK12
  2                                              NM_172782   NM_018698   NXT2       *Nuclear transport factor 2-like export factor 2*               Xq23            PARK12

###### 

Candidate genes for non-OMIM PARK loci

  GenBank ID                                                      Human ID       Symbol     Human location     In kb^b^   Gene name
  --------------------------------------------------- ----------- -------------- ---------- ------------------ ---------- -------------------------------------------------------------------------------------------------------------------
  Scott (01) D3S2460^26^                                                                                                  
  5                                                   NM_008083   NM_002045      GAP43      3q13.1--13.2       116700     *Growth-associated protein 43*
  3                                                   BB626331    EST            Lsamp      3q13.2--q21        117200     *Limbic system-associated membrane protein*
  2                                                   NM_177093   XM_057296      LRRC58     3q13.33            121300     *Leucine-rich repeat containing 58*
  2                                                   NM_008047   NM_007085      FSTl       3q13.32--q13.3     121460     *follistatin-like 1*
  Martinez (04) D5S471^29^                                                                                                
  1                                                   XM_283496   NM_005509      DMXL1      5q22               118600     *Dmx-like 1*
  1                                                   Genomic     Estimated      FEM1C      5q22               114939     fem-1 homolog c
  3                                                   NM_152809   NM_004384      CSNK1G3    5q23               123000     *Casein kinase 1, gamma 3*
  Li (02) D5S1462 D5S1453^21^                                                                                             
  1                                                   NM_172827   EST            LNPEP      5q15               96440      *Leucyl/cystinyl aminopeptidase*
  Hicks (02). Scott (01) D5S666. D5S816^26,55^                                                                            
  1                                                   NM_173753   NM_001008738   FNIP1      5q31.1             131060     *Folliculin interacting protein 1*
  1                                                   NM_144823   NM_015256      ACSL6      5q31               131400     *Acyl-CoA synthetase long-chain family member*
  1                                                   NM_033144   XM_034872      SEPT8      5q31               132180     *Septin 8*
  1                                                   AK011363    NM_003337      UBE2B      5q23--q31          133800     *Ubiquitin-conjugating enzyme E2B, RAD6 homology*
  Scott (01) D5S816^26^                                                                                                   
  1                                                   NM_029518   NM_016604      JMJD1B     5q31               137810     *Jumonji domain containing 1B*
  3                                                   NM_010771   NM_018834      MATR3      5q31.3             138730     *Matrin 3*
  Li (02) D6S1017^21^                                                                                                     
  1                                                   NM_025365   NM_013397      C6ORF49    6p21.31            41800      *Chromosome 6 open reading frame 49*
  1                                                   NM_020493   NM_003131      SRF        6p21.1             43200      *Serum response factor (c-fos serum response element-binding transcription factor)*
  5                                                   NM_008302   NM_007355      HSP90AB1   6p12               44300      *Heat shock protein 90 kDa alpha (cytosolic), class B member 1*
  Martinez (04) D6S257 D6S460^29^                                                                                         
  1                                                   Genomic     Estimated                 6q12--q13          72500      
  8                                                   NM_010106   NM_001402      EEF1A1     6q14.1             74224      *Eukaryotic translation elongation factor 1 alpha 1*
  Martinez (04) D7S531^29^                                                                                                
  1                                                   NM_028469   NM_032350      MGC11257   7p22.3             850        *Hypothetical protein MGC11257*
  1                                                   NM_010302   NM_007353      GNA12      7p22--p21          2510       *Guanine nucleotide binding protein (G protein) alpha 12 *
  6                                                   NM_007393   NM_001101      ACTB       7p15--p12          5300       *Actin beta*
  1                                                   NM_026050   NM_032706      MGC12966   7p22.2             6110       *Hypothetical protein MGC12966*
  1                                                   NM_009007   NM_006908      RAC1       7p22               6170       *ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac)*
  DeStefano (01) D9S1825,^56^ Scott (01) D9S301^26^                                                                       
  7                                                   NM_026434   NM_033117      RBM18      9q34.11            120400     *RNA binding motif protein 18*
  2                                                   NM_022310   NM_005347      HSPA5      9q33--q34.1        123370     *Heat shock 70 kD protein 5*
  1                                                   NM_025709   NM_015635      GAPVD1     9q34.11            123450     *GTPase-activating protein and VPS9 domains 1*
  1                                                   NM_172661   XM_497080      KIAA0515   9q34.1             129650     *KIAA0515 gene*
  DeStefano (01) GATA121A08^56^                                                                                           
  1                                                   NM_183295   NM_015634      KIAA1279   10q22.1            70100      *KIAA1279 gene*
  Martinez (04) D11S4175^29^                                                                                              
  1                                                   NM_025844   NM_012124      CHORDC1    11q14.3            89650      Cysteine and histidine-rich domain (CHORD)-containing. zinc-binding protein 1
  Li (02) D10S1239^21^                                                                                                    
  1                                                   NM_172523   NM_003054      VMAT2      10q25              118680     Solute carrier family 18
  Li (02) D17S1303^21^                                                                                                    
  1                                                   NM_018768   NM_004853      STX8       17p12              9350       Syntaxin 8
  Scott (01) D17S921, D17S1293^26^                                                                                        
  1                                                   NM_011664   NM_018955      UBB        17p12--p11.2       16470      *Ubiquitin B*
  1                                                   NM_011480   NM_004176      SREBF1     17p11.2            17950      *Sterol regulatory element binding factor 1*
  1                                                   XM_110937   NM_145809      USP32      17p11.2            18621      *Ubiquitin-specific protease 32*
  1                                                   NM_026389   NM_015584      POLDIP2    17q11.2            26800      *Polymerase delta interacting protein 2*
  1                                                   NM_174852   NM_020889      PHF12      17q11.1            27400      *PHD finger protein 12*
  1                                                   NM_010897   NM_000267      NF1        17q11.2            29700      *Neurofibromatosis 1*
  1                                                   NM_010161   NM_014210      EVI2A      17q11.2            29800      *Ecotropic viral integration site 2A*
  1                                                   NM_010716   NM_002311      LIG3       17q11.2--q12       33450      *Ligase III, DNA, ATP-dependent*
  Bertoli-Avella (03) D19S221^27^                                                                                         
  2                                                   NM_008319   NM_003259      ICAM5      19p13.2            10260      *Intercellular adhesion molecule 5, telencephalin*
  16                                                  NM_016742   NM_007065      CDC37      19p13.2            10370      *Cell division cycle 37 homolog (S. cerevisiae)-like*
  1                                                   NM_145624   NM_016264      ZNF44      19p13.2            12200      *Zinc finger protein 44*
  1                                                   NM_010906   NM_002501      NFIX       19p13.3            13030      *Nuclear factor I/X*
  1                                                   NM_183097   Estimated                 19p13.13           14060      *Progestin and adipoQ receptor family member*
  DeStefano (02) D20S478^56^                                                                                              
  1                                                   BQ927659    Estimated                 20q11.2--q12       35330      
  1                                                   NM_013865   NM_022477      NDRG3      20q11.21--q11.23   36000      *n-myc downstream regulated 3*
  1                                                   NM_010658   NM_005461      MAFB       20q11.2--q13.1     40000      *v-maf musculoaponeurotic fibrosarcoma oncogene family. protein B*
  2                                                   NM_021464   NM_007050      PTPRT      20q12--q13         40500      *Protein tyrosine phosphatase. receptor type T*
  DeStefano (02) D21S2052^56^                                                                                             
  2                                                   NM_11782    Estimated      ADAMTS5    21q21.2            27170      *A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif 5 (aggrecanase-2′) 3′*
  Pankratz (03) DXS8055^24^                                                                                               
  1                                                   NM_016783   NM_006667      PGRMC1     Xq24               116713     *Progesterone receptor membrane component 1*

Listed genes are situated ± 3 Mb to peak with the highest LOD score, except for D10S196 where we used ± 8Mb.

^a^Number of cDNA fragments aligning with the gene.

^b^kb from the top of the short arm of the chromosome.

^c^Human chromosome location was estimated by comparing the flanking regions of mouse and man.

The experimental design of the three different transcriptome analyses, we used for our study, were such that they included both highly and rarely expressed transcripts. Our analysis confirmed the complementary nature of the three screens. Only 7.2% (104 out of 1435) of the cDNA sequences of these libraries represent genes, hypothetical genes, or EST clusters, which are found in more than one of them (Table [8](#DSM007TB8){ref-type="table"}). Moreover, the libraries also contained two cDNA fragments for α-*synuclein*, three for *NR4A2*, and one for the *tau* genes. Mutations in all three genes have been previously associated to PD.^[@DSM007C5],[@DSM007C30],[@DSM007C36]^ Assuming that all 30 000 genes in the human genome^[@DSM007C61]^ were equally likely detected, the probability to identify three of nine PD susceptibility genes by chance out of a pool of 569 was less than 3.4 × 10 ^−3^. If we exclude the controversial *NR4A2 and UCHL1*, the probability was less than 1.5 × 10^−2^.

###### 

cDNA library comparison

            Barrett^52^   Stewart^53^   Thuret^54^
  --------- ------------- ------------- ------------
  Barrett                 45 (22)       11 (2)
  Stewart   35 (22)                     5 (4)
  Thuret    3 (2)         5 (4)         

Of 1435, 104 (7.2%) cDNA fragments overlap with sequences also present in one other library. This number includes not only fragments that align with each other, but also those which align with the same annotated gene, hypothetical gene, mitochondrial gene, EST, or genomic position. These overlapping 104 cDNA fragments represent 28 of 781 (3.6%) unique tags (Table [2](#DSM007TB2){ref-type="table"}).

4.. Discussion {#s4}
==============

The entire human and mouse genome sequences have been available for more than 3 years.^[@DSM007C61],[@DSM007C62]^ Therefore, the chromosomal locations of most genes have been determined and as a consequence also those genes within a given disease locus. In order to identify potential PD susceptibility genes, we projected the sequence data of three murine transcriptome studies for mesDA neurons onto the human genome and compared them with previously identified PD loci. We determine the human homologs of 1435 murine cDNA fragments which corresponded to 579 unique *mouse* chromosomal locations; 423 annotated genes, 80 hypothetical genes, 32 ESTs, and 44 genomic locations, which are not linked to any genes or otherwise reported cDNA sequences. Of the 569 unique locations on the human genome, 19 were positioned in OMIM PARK loci and 51 within genomic regions that have a weaker linkage to PD, which are not recorded in the OMIM database and need further confirmation.

Multiple studies are on the way to determine the underlying mutations of *orphan* PARK loci^[@DSM007C63]^; however, the length of putative regulatory regions of most gene, their unpredictable position, and the common presence of SNPs have thus far restricted such studies to nucleotide variation in the coding region and in 5′ and 3′ UTR. Disparities in the promoter--enhancer--silencer regions were only the aim if the targeted gene had been previously linked to PD.^[@DSM007C64],[@DSM007C65]^ A nucleotide variation in the α-*synuclein* promoter, for example, was associated to the disease.^[@DSM007C12],[@DSM007C66]^ Variability on the level of gene expression is far more common than nucleotide variations which alter protein sequences^[@DSM007C67]^ and it is believed that these haplotype variations determine individual traits and predispositions for common diseases such as PD. Narrowing down the number of candidate genes in identified loci in a rational manner may encourage the inclusion of the promoter regions in future studies aiming to identify mutations associated to PD.

Among the candidate genes that we found, the most interesting is *VMAT2* (*vesicular monoamine transporter 2*) (10q25). Reduced expression of *VMAT2* could be correlated with a higher sensitivity to environmental factors. For example, *VMAT2* heterozygote mice (+/ − ) are remarkably more sensitive than wild-type to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.^[@DSM007C68],[@DSM007C69]^ Furthermore, we identified two genes in the ubiquitination pathway, *Ube2b* \[*ubiquitin-conjugating enzyme E2B, RAD6 homology* (*S. cerevisiae*)\] and *Ubb* (*Ubiquitin B*, member of the *HSP90* family) and *Hspa5* (heat shock 70 kDa protein 5, member of the *HSP70* family).

Finally, 26 mitochondrial genes encoded by nuclear DNA are present in our transcriptome analysis. Of these, an unexpected high proportion of genes, namely four, are located within *orphan* OMIM PARK loci. There is increasing evidence that impairment of mitochondrial functions and oxidative stress are contributing factors to PD^[@DSM007C70]^ supported by the recent finding of a mutation in *PINK1*.^[@DSM007C35]^ Furthermore, the functional deficiencies induced by several of the other PD mutations seem to converge onto the mitochondria.^[@DSM007C71]^ Our finding confirms a central role of the mitochondria in PD and suggests the possibility that a misregulation of some of these four mitochondrial genes may be a contributing factor for the disease.

We conclude that our transcriptome analysis, along with being applicable for the identification of PD candidate genes, may also be a useful tool for future genome-wide association studies with newer resources, such as HapMap (<http://www.hapmap.org/>), where tagSNPs can be chosen close to loci of genes expressed by mesDA neurons. Furthermore, new GO annotations are constantly added and with time it may turn out that many of the identified genes are part of shared metabolic pathways. Our data set may give new insight into ligand/receptor interactions and/or intracellular signaling pathways acting in mesDA neurons, allowing novel studies into the molecular etiology of PD.
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Supplementary Data {#s5}
==================

Supplementary data are available online at [www.dnaresearch.oxfordjournals.org](www.dnaresearch.oxfordjournals.org).
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